专利检索 ap:"ALTERMUNE LIMITED" 第 1 页

1.

发明授权
Aptamers against EGFR and therapeutic uses thereof 有权

公开(公告)号：US10190121B2

公开(公告)日：2019-01-29

申请号：US15320929

申请日：2015-06-23

申请人： Altermune Limited

发明人： Bradley Hall , Paul Hatala

IPC分类号： C12N15/115

摘要： The invention relates to novel aptamers, in particular aptamers which are capable of binding to EGFR. The invention also relates to cancer cell binding complexes comprising said aptamers and the use of said cancer cell binding complexes in the treatment of cancer.

2.

发明申请
APTAMERS AGAINST EGFR AND THERAPEUTIC USES THEREOF 审中-公开

公开(公告)号：US20170130226A1

公开(公告)日：2017-05-11

申请号：US15320929

申请日：2015-06-23

申请人： ALTERMUNE LIMITED

发明人： Bradley HALL , Paul HATALA

IPC分类号： C12N15/115

CPC分类号： C12N15/115 , C12N2310/16 , C12N2310/317 , C12N2310/321 , C12N2310/322 , C12N2310/344 , C12N2310/351 , C12N2310/3513 , C12N2320/51 , C12N2310/3533 , C12N2310/3521

摘要： The invention relates to novel aptamers, in particular aptamers which are capable of binding to EGFR. The invention also relates to cancer cell binding complexes comprising said aptamers and the use of said cancer cell binding complexes in the treatment of cancer.